Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/186202
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDarbà, Josep-
dc.date.accessioned2022-06-02T12:13:47Z-
dc.date.available2023-03-01T06:10:27Z-
dc.date.issued2022-03-01-
dc.identifier.issn1473-7167-
dc.identifier.urihttp://hdl.handle.net/2445/186202-
dc.description.abstractThe prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing worldwide, which is expected to correlate with significant medical and social costs. This study aimed to evaluate the clinical and economic burden of NAFLD in Catalonia at the hospital level.-
dc.format.extent9 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherInforma Healthcare-
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1080/14737167.2021.1890586-
dc.relation.ispartofExpert Review of Pharmacoeconomics & Outcomes Research, 2022, vol. 22, num. 2, p. 341-349-
dc.relation.urihttps://doi.org/10.1080/14737167.2021.1890586-
dc.rights(c) Informa Healthcare, 2022-
dc.sourceArticles publicats en revistes (Economia)-
dc.subject.classificationTractament de l'alcoholisme-
dc.subject.classificationPolítica sanitària-
dc.subject.classificationCost de l'assistència sanitària-
dc.subject.otherAlcoholism treatment-
dc.subject.otherMedical policy-
dc.subject.otherCost of medical care-
dc.titleDirect medical costs of non-alcoholic fatty liver disease in Catalonia at the hospital level: a retrospective multicenter study-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/acceptedVersion-
dc.identifier.idgrec707001-
dc.date.updated2022-06-02T12:13:47Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Economia)

Files in This Item:
File Description SizeFormat 
707001.pdf1.16 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.